While the 35-member team hasn’t yet revealed development timelines for the programs, Khoshakhlagh said the biotech is moving ...

Employees at Achilles Therapeutics are bracing themselves for job losses after the UK biotech announced that it is dropping ...

Investing in biotech stocks can be risky, particularly in the clinical stage, since their success often hinges on the results ...

The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks ...

Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...

As investors look for undervalued assets amidst the broader market uncertainty, penny stocks offer potential opportunities ...

As of 1:24 PM EDT. Market Open. DURHAM, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company ...

Renowned Harvard geneticist and serial entrepreneur George Church is at it again, with a venture that has raised $75 million ...

Five months after Rakovina Therapeutics pivoted toward artificial intelligence, the cancer-focused biotech has joined forces ...

Almaden—which was formerly part of IBM Research before launching as a standalone company in 2022 under Catalyze Dallas ...

Vir Biotechnology has concluded a deal with Sanofi, enabling access to multiple T-cell engages and the PRO-XTEN masking ...